SCHEMBL172775

SCHEMBL172775

O=C(O)c1cccc(N2C(=O)CN(c3cccc(N4CC(=O)N(c5cccc(C(=O)O)c5)C4=O)c3)C2=O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
HPGD P15428 2/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
KMT2A Q03164 8/20 0.56
CMA1 P23946 2/20 0.55
L3MBTL1 Q9Y468 5/20 0.54
CTSG P08311 1/20 0.53
MEN1 O00255 7/20 0.51
GAA P10253 3/20 0.51
MAPT P10636 2/20 0.51
KDM4E B2RXH2 3/20 0.50
HSD17B10 Q99714 2/20 0.50
POLB P06746 3/20 0.48
BLM P54132 2/20 0.48
TYMS P04818 1/20 0.47
KMO O15229 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL172529 0.98 ALDH1A1 (0.61) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL171088 0.92 ALDH1A1 (0.55) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL10187356 0.90 ALDH1A1 (0.53) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL172752 0.90 ALDH1A1 (0.53) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL171096 0.89 CMA1 (0.52) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL171102 0.88 ALDH1A1 (0.51) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL131523 0.88 ALDH1A1 (0.51) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL131981 0.88 CMA1 (0.51) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL133701 0.88 KMT2A (0.53) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL172580 0.88 CMA1 (0.54) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1542667-B1 UREIDO SUBSTITUTED BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE PTC THERAPEUTICS INC (US) 2012-03-07 EP disclosed